F. Michael Ball has been promoted as president of Allergan after 10 years with the company. As executive vice president and president of its pharmaceuticals division since 2003, he has been instrumental in the reorganization of global commercial operations. David E.I. Pyott remains as chairman and chief executive of the ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.